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Chytridiomycosis causes 
catastrophic organism-wide 
metabolic dysregulation including 
profound failure of cellular energy 
pathways
Laura F. Grogan  1,2, Lee F. Skerratt2, Lee Berger2, Scott D. Cashins2, Robert D. Trengove3,4 & 
Joel P. A. Gummer  3,4
Chytridiomycosis is among several recently emerged fungal diseases of wildlife that have caused 
decline or extinction of naïve populations. Despite recent advances in understanding pathogenesis, 
host response to infection remains poorly understood. Here we modelled a total of 162 metabolites 
across skin and liver tissues of 61 frogs from four populations (three long-exposed and one naïve to the 
fungus) of the Australian alpine tree frog (Litoria verreauxii alpina) throughout a longitudinal exposure 
experiment involving both infected and negative control individuals. We found that chytridiomycosis 
dramatically altered the organism-wide metabolism of clinically diseased frogs. Chytridiomycosis 
caused catastrophic failure of normal homeostatic mechanisms (interruption of biosynthetic and 
degradation metabolic pathways), and pronounced dysregulation of cellular energy metabolism. 
Key intermediates of the tricarboxylic acid cycle were markedly depleted, including in particular 
α-ketoglutarate and glutamate that together constitute a key nutrient pathway for immune processes. 
This study was the first to apply a non-targeted metabolomics approach to a fungal wildlife disease 
and specifically to dissect the host-pathogen interface of Bd-infected frogs. The patterns of metabolite 
accumulation we have identified reveal whole-body metabolic dysfunction induced by a fungal skin 
infection, and these findings have broad relevance for other fungal diseases.
Recently emerged fungal skin diseases of wildlife include chytridiomycosis in amphibians, white nose syndrome 
in bats, snake fungal disease and mucormycosis in platypus1,2. Knowledge is needed urgently to develop novel 
approaches for control3,4. While targeted metabolite studies have documented host changes associated with white 
nose syndrome and chytridiomycosis5,6, there have been no broad scale metabolomics studies investigating these 
fungal diseases excepting those aimed at identifying anti-microbial peptides or probiotics7. Chytridiomycosis 
is an often fatal fungal skin disease of amphibians, affecting approximately 42% of species examined8 and caus-
ing declines and extinctions around the world9. Fungal sporangia invade the superficial epidermal cells lead-
ing to disrupted skin functions involving ion transport10. While the proximate cause of mortality due to the 
pathogen, Batrachochytrium dendrobatidis (hereafter Bd) has been linked with alteration of electrolyte balance 
(low plasma levels of sodium and potassium) and subsequent cardiac arrest10, the accompanying host metabolic 
phenotype has not been well characterized. Several gene expression studies have identified pathways associated 
with end-stage physiology. These include increased expression of genes associated with cellular stress and dis-
ruption of skin homeostasis, detoxification, proteases, antimicrobial peptides, as well as decreased expression 
of cytochrome p450 genes, blood coagulation genes and immune genes (although recent evidence suggests the 
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degree and efficacy of immune response may differ between species)11–18. An improved understanding of the 
molecular basis underlying the pathophysiology of chytridiomycosis will be fundamental to improving manage-
ment techniques and hence population outcomes3. In addition, comparing the metabolome of populations with 
differing long-term exposure histories and susceptibility to Bd may elucidate immune mechanisms associated 
with more resistant or tolerant phenotypes.
Non-targeted metabolomics (otherwise known as metabonomics or metabolic phenotyping when undertaken 
to investigate and compare disease states) seeks to measure the small molecule ( <1,500 daltons) component of 
a biological system. It investigates the precursors, intermediates and products of biochemical pathways (includ-
ing for example amino acids, organic acids, sugars and nucleotides19,20), as well as exogenous influences such as 
occurring through exposure events. Mass spectrometry (MS) and chemometrics are the cornerstone of modern 
metabolomics research, capable of discriminating thousands of metabolic features to characterize a metabolic 
phenotype, or ‘phenome’21. Non-targeted metabolomics analyses can identify patterns of metabolite flux to eluci-
date biochemical perturbations induced by infection and disease21. Such insights have led to the development of 
numerous assays for screening biomarkers of disease, particularly in humans22–24. Metabolomics approaches have 
also been widely used in toxicological and pharmacological studies7,25,26.
To date, numerous studies have used mass spectrometry to characterize the interaction between Bd and the 
amphibian host including investigations of intra and extracellular fungal metabolites, amphibian urinary met-
abolic markers of stress, epidermally secreted antimicrobial peptides, and the analysis of antifungal metabolites 
produced by symbiotic skin bacteria7,27–32. These studies have greatly furthered our understanding of frog-fungal 
pathosystems. Thus far, however, no study has attempted to examine the overall metabolic phenotype (including 
intracellular and within multiple cell types and organs) associated with chytridiomycosis throughout pathogen-
esis. Moreover, no study has yet examined differences in metabolic phenotype among different populations of 
a single frog species with varying exposure histories and clinically demonstrated differential susceptibility to 
disease.
In this study we used a non-targeted metabolomics approach to examine the longitudinal metabolic pheno-
type of chytridiomycosis infection post exposure, as well as to compare the metabolome of different populations 
of the same species with differing long-term Bd-exposure histories and survival responses. We analyzed skin 
tissues at the site of infection, as well as liver tissues from exposed and unexposed control frogs at multiple time 
points throughout disease progression (subclinically at four, eight and 14 days post exposure, and in clinically 
diseased animals).
Materials and Methods
Sample collection. Ethics Statement. Wild alpine tree frog eggs (Litoria verreauxii alpina) were collected 
by D. Hunter in accordance with Scientific License number: S12848. Animals were captively-raised by expe-
rienced animal handlers under quarantine conditions following Taronga Conservation Society Animal Ethics 
Committee guidelines (4c/01/10). Experimental protocols involving animals were similarly carried out in accord-
ance with the approved guidelines and protocols under permits issued by James Cook University (A1408) and 
Taronga Conservation Society (4c/01/10) Animal Ethics Committees. Animals were individually examined at 
least once daily for clinical signs of chytridiomycosis infection (lethargy, peripheral erythema and increased skin 
shedding), and humanely euthanized if clinical signs were detected (typically indicative of end-stage disease)33,34.
Study subjects, exposure experiment and sampling. Source populations, study subjects, exposure exper-
iment and sampling protocols are described in detail by Grogan et al.33 (refer to Experiment B). In brief, 61 
chytridiomycosis-naïve adult alpine tree frogs were captively-raised from wild-caught eggs collected from four 
geographically distinct populations in Kosciuszko National Park, New South Wales, Australia. Batrachochytrium 
dendrobatidis had emerged at three of these sites (hereafter Kiandra, Eucumbene and Ogilvies) over two decades 
earlier than the time of egg collection (as determined via long-term monitoring33). The remaining site (hereafter 
Grey Mare) was known to be Bd-naïve at the time of egg collection. Forty-six of these frogs were individually 
exposed to 750,000 zoospores of Bd using the AbercrombieNP-L.booroolongensis-09-LB-P7 isolate in a topical 
bath of dilute salts solution (DSS)33, while the remaining 15 frogs were sham-exposed with only DSS (unexposed 
negative control group). Seventeen animals (including both exposed and control animals across populations) at 
each of three subclinical sampling sessions (at either 4, 8 or 14 days post-exposure) were skin-swabbed to quantify 
Bd infection intensity, euthanized and then had skin and liver tissues sampled. The remaining 10 animals were 
swabbed, euthanized and sampled at the onset of clinical signs (between 28 and 30 days post-exposure; see Table 1 
for details of experimental design). Ventral abdominal skin (common site of infection) and liver tissues were 
collected into 500 µL 100% methanol and stored at −80 °C.
Metabolomics methods. Isolation, preparation and GC-MS analysis. Details of the metabolomics prepara-
tive methods are provided by Grogan et al.33. In brief, harvested liver and skin tissues were dried by lyophilisation, 
homogenized via agitation, and metabolites extracted into a methanol supernatant via centrifugation, before being 
dried via vacuum concentration and lyophilisation. An additional pooled extract was created for follow-up analyses. 
The metabolites were then trimethylsilyl (TMS) derivatised in preparation for gas chromatography mass spectrome-
try (GC-MS) as previously described33. Five µL of hexane containing a series of straight-chain alkanes was added to 
samples for the calculation of retention indices (RIs). The GC-MS (Shimadzu QP2010 Ultra, Kyoto, Japan) analysis 
of the metabolite derivatives was described by Grogan et al.33, with data acquired and analysed using GCMSsolution 
2.61 (Shimadzu Corporation, Kyoto, Japan) and AnalyzerPro 2.7.0.0 (Spectral Works, Runcorn, UK). A prelimi-
nary scan acquisition (m/z 50–650) was followed by a simultaneous full scan and selective ion monitoring (SIM) 
mode of acquisition. Gas Chromatography Mass Spectrometry analyses of skin samples were not obtained for 
seven frogs (five from Kiandra, one from Eucumbene and one from Grey Mare) due to a precipitate that formed in 
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the derivatised samples (we could not identify the cause for the precipitate). All analytes were relatively quantified 
using a characteristic quantifier ion selected for each analyte, and metabolite identities assigned by comparison to 
authentic metabolite standards or by reference to an external mass spectral library (Massbank, National Institute of 
Standards and Technology (NIST) or Wiley Registry™). Metabolites without a match were labelled with the prefix 
‘unknown’, followed by the observed retention time (RT) and calculated RI. Quality control and technical validation 
procedures are described in detail by Grogan et al.33.
Data analysis and interpretation. Measured analytes of non-biological origin were determined by com-
parison to no-tissue control preparations, which were prepared identically to the sample extracts, but without skin 
or liver tissue. Any non-biological analytes were subsequently removed from the data matrices. Peak areas were 
normalized to the summed total ion intensity35, subsequently log transformed36 (log10(x + 1)) and pareto-scaled 
(mean-centered values are divided by square root of the standard deviation37). Statistical analyses were performed 
with SPSS (IBM, USA), R (Bell Laboratories), and Metaboanalyst 3.638. For ease of interpretation, data from 
sham-exposed negative control group frogs (for all analyses except batch effect analyses) were designated Group 
0, regardless of whether they were sampled at 4, 8 or 14 days post-exposure. Exposed/infected frogs sampled at 
various times post-exposure were designated Groups 1, 2, 3 and 4, corresponding to being sampled at 4, 8, 14 and 
28–30 days post exposure, respectively. The numbers of samples included in each group for each analysis have 
been described below, and varied depending on original sample size and taking into account any missing values.
Traditional univariate statistical analyses included Analysis of Variance with post-hoc Tukey’s Honestly 
Significant Difference (HSD) tests, a pattern matching correlation analysis with Pearson r correlation39, and 
Significance Analysis of Microarrays (SAM40). In all cases, an alpha error level of 0.05 corrected for multiple 
testing via Bonferroni method was considered acceptable (corresponding to a false discovery rate, FDR < 0.05). 
Multivariate analyses included unsupervised Principal Components Analysis (PCA) and supervised Partial Least 
Squares Discriminant Analysis (PLS-DA) providing Variable Importance in Projection scores (VIP) with model 
quality assessed by 10-fold cross-validation based on Q2 and goodness of fit evaluated with permutation testing 
using 2,000 iterations. We also used the Omics Dashboard41 to explore patterns of metabolite accumulation and 
depletion across metabolic pathways and cellular systems in response to chytridiomycosis. Population compar-
isons excluded data on the two frogs from Ogilvies due to small sample size, however these were included in the 
sample period based analysis. Metabolites found most influential within the data modelling were searched for 
in intracellular and extracellular metabolite analyses of Bd sporangia and culture medium (data not shown), to 
determine if of frog or fungal origin.
Results
Clinical characteristics and summary results. All 61 experimental animals survived the duration of 
the experiment until they were euthanized for sampling. As expected, the 10 frogs sampled between 28 and 30 
days post-exposure were demonstrating clinical signs of chytridiomycosis (muscle weakness, lethargy, peripheral 
erythema or inability to maintain normal upright posture) at the time of euthanasia. Demographic data on the 
sampled frogs, together with infection intensities as assessed via qPCR can be found in Table 2. Data from a con-
current large survival experiment using other animals from these same populations demonstrated that frogs from 
Kiandra survived significantly longer when compared with frogs from the other populations33,42,43.
Overall, 23,868 MS features were resolved by GC-MS across both liver and skin tissues with a total of 2,177 
zero values and no missing values. The MS features were deconvoluted into peaks representing individual metab-
olites and the relative quantitation of 162 metabolites was obtained, with 72 of these metabolites identified or 
putatively identified. Complete metabolite accumulation data have been archived at the MetaboLights data repos-
itory and Dryad Data Repository (details in Grogan et al.33). While we refer to acid analytes by their library stand-
ard name in the results, in the discussion we instead refer to the equivalent anion salt with the suffix ‘-ate’ (ie, citric 
acid becomes citrate), as this is the biologically relevant form.
The effect of sample processing was identified to be minimal via a batch effect PCA analysis, consistent with 
preventative GC-MS maintenance regimens (see Supplementary Fig. S1 and Grogan et al.33). It was also clear 
from this analysis that the metabolite profiles of skin tissue samples clustered separately from liver samples, as 
expected with differential underlying tissue physiology. Skin and liver samples from the frog designated Lva259 
from the Grey Mare population were consistently found to be marked outliers in the PCA results (across analyses; 
see Supplementary Fig. S1), and hence were removed from further analysis. These two samples may have been 
outliers due to tissue autolysis post mortem that may have altered the metabolic profile relative to other samples 
(this individual died from chytridiomycosis in the short interval between swabbing and euthanasia).
Populations
Exposure – Day 0
Total # exposed
(total # control)a
Day 4
# exposed sampled
(# control sampled)b
Day 8
# exposed sampled
(# control sampled)b
Day 14
# exposed sampled
(# control sampled)b
Clinically diseased
(Day 28+)
# exposed sampled
Grey Mare 16 (3) 4 (1) 4 (1) 4 (1) 4
Eucumbene 14 (6) 4 (2) 4 (2) 4 (2) 2
Kiandra 14 (6) 4 (2) 4 (2) 4 (2) 2
Ogilvies 2 — — — 2
Table 1. Experimental design outlining the number of frogs from each population and treatment group (Bd 
exposed or unexposed control) sampled at each time point post exposure. aTotal number of unexposed control 
frogs shown in parentheses; bNumber of unexposed control frogs sampled shown in parentheses.
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Sampling period comparisons. Univariate analyses. One-way ANOVA of skin samples identified 33 
metabolites (7 unidentified) as differing significantly in relative concentration between sampling periods (for this 
analysis, Groups 0–4 contained 13, 11, 10, 12 and 7 samples respectively). Tukey’s HSD post-hoc tests identified 
the 10 most significantly differing (FDR < 0.05) metabolites between sampling groups to include α-ketoglutaric 
acid, serotonin, 5-hydroxyindole-3-acetic acid (5HIAA), isoleucine, glutamic acid, ornithine, tartaric acid, urea, 
threonine, and serine (Supplementary Table S1). Most of these were associated with lower concentrations in the 
clinically diseased group of frogs (Group 4) compared with both negative control and subclinical groups (Groups 
0–3), except for 5HIAA and isoleucine (where Group 4 was relatively higher), urea (where Groups 1 and 4 were 
low) and lysine (where Group 1 was low) (Fig. 1A). The metabolites differing significantly in relative concentra-
tion between Groups excluding the clinically diseased group (ie, only among Groups 0–3) included ornithine, 
urea, threonine, serine, adenine, putrescine and lysine (Supplementary Table S1). The t-test pattern matching 
approach using a time-series pattern (Groups 0–4 in order) yielded some differences to the above list. The 10 
most significantly differing metabolites identified included α-ketoglutaric acid, putrescine, adenine, threonine, 
tartaric acid, adenosine, glutamic acid, pyroglutamic acid, cellobiose and myo-inositol (Supplementary Table S2). 
The SAM analysis identified the following top 10 metabolites as significantly different in concentration between 
sampling periods: α-ketoglutaric acid, serotonin, 5HIAA, urea, glutamic acid, serine, threonine, ornithine, iso-
leucine, and lysine (Supplementary Table S3).
Liver samples grouped by sampling period and analyzed with one-way ANOVA revealed 79 metabolites as 
differing significantly in relative concentration, 43 of which were positively identified (Groups 0–4 contained 
15, 12, 12, 12 and 9 samples respectively). The top 10 identified and most significantly differing metabolites 
via Tukey’s HSD post-hoc tests included isoleucine, glutamic acid, pyroglutamic acid, leucine, putrescine, 
fructose-6-phosphate, citric acid, fumaric acid, glucose-6-phosphate and γ-aminobutyric acid (GABA; 
Supplementary Table S4). Once again, the majority of these were associated with lower concentrations in the 
clinically diseased group of frogs (Group 4) compared with the remaining sample Groups (Groups 0–3), except 
for isoleucine, leucine and putrescine which were all elevated in Group 4 (Fig. 1B). Top identifiable metabolites 
that differed significantly between subclinical and control groups included isoleucine, leucine, GABA, serine, 
sucrose and cellobiose (Supplementary Table S4). Searching for patterns matching the time-series of sampling 
periods (similar to above) yielded the following top 10 identifiable metabolites as being highly significant: glu-
tamic acid, pyroglutamic acid, putrescine, isoleucine, leucine, GABA, serine, creatine, citric acid and fuma-
ric acid (Supplementary Table S5). The SAM analysis presented different rankings, including the following as 
the 10 most significant identifiable metabolites: 5HIAA, citric acid, putrescine, α-ketoglutaric acid, galactose, 
fructose-6-phosphate, creatine, glucose-6-phosphate, isoleucine and lysine (Supplementary Table S6).
Multivariate analyses. Supervised partial least squares discriminant analysis (PLS-DA) demonstrated marked 
separation between clinically diseased frog tissues (Group 4) and control and subclinically infected tissues 
(Groups 0–3), an effect most pronounced within the liver tissue samples (Fig. 2). The top 30 metabolites ranked 
by VIP scores based on component one for skin samples grouped by sampling period revealed the following 
identified metabolites: α-ketoglutaric acid, putrescine, adenine, threonine, serine, lysine, aspartic acid, serotonin, 
and cellobiose (Supplementary Table S7, Fig. 1A). Variable importance in projection scores for liver samples 
grouped by sampling period yielded the following metabolites as most important ranked by component one: 
galactose, 5HIAA, putrescine, citric acid, creatine, α-ketoglutaric acid, fructose-6-phosphate, GABA, lysine, iso-
leucine, urea, glutamic acid, and pyroglutamic acid (Supplementary Table S8, Fig. 1B).
Pathway analyses. Interactive exploration (Omics Dashboard41) of skin and liver tissue metabolite accumula-
tion data grouped by sampling period revealed substantial alterations in cellular system profiles in clinically dis-
eased frogs. Most notably, numerous metabolites associated with biosynthetic, degradation and energy pathways 
were depleted in moribund frogs (Group 4) compared with control and subclinically infected frogs (Groups 0–3; 
see Fig. 3). Nucleotide, carbohydrate, secondary metabolism, cofactor and hormone pathways were markedly 
affected in both skin and liver tissues of moribund animals (biosynthesis and degradation decreased). Metabolites 
Kiandra Eucumbene Grey Mare Ogilvies P 
valuea dfaExposed Control Exposed Control Exposed Control Exposed
Sample size 14 6 14 6 16 3 2
Genderb 3M, 4F, 7U 2M, 4U 3M, 6F, 5U 1M, 5F 5M, 7F, 4U 2F, 1U 1M, 1F
Mean mass at death 3.21 3.02 2.95 4.05 3.43 3.19 3.29 0.917 3
Mean SUL at deathc 30.29 30.72 28.79 32.10 32.01 32.03 31.80 0.150 3
Mean ZSE at deathd 429122.80 0.28 145852.98 0.00 148017.50 0.00 614937.50 0.697 3
Median ZSE at death 705.83 0.00 185.83 0.00 5955.83 0.00 614937.50
Table 2. Demographic characteristics of study subjects (including sample size, treatment group, gender ratios, 
mean mass at death, mean snout-urostyle length at death and mean and median infection intensity at death). 
aStatistics comparing means between populations (pooling exposed and control frog values) using one-way 
ANOVA, P value and df degrees of freedom; bGenders represented by M for males, F for females and U for 
unknown gender; cSUL is snout-urostyle length measured with Vernier callipers; dZSE is zoospore equivalents 
as measured by qPCR.
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associated with metabolic regulation synthesis were also depleted in both tissues. Amino acid and amine biosyn-
thetic and degradation pathways were particularly decreased in the skin of moribund animals. Metabolites associ-
ated with detoxification pathways were also depleted in both skin and liver tissues of moribund frogs. Metabolites 
Figure 1. Box and whisker plots (with data points overlaid) of the relative concentration of identified 
metabolites of interest according to their sampling group (using geom_boxplot from ggplot2 R package). (A) 
Metabolites from skin samples, (B) metabolites from liver samples. Sham-exposed negative control group frogs 
were designated Group 0. Exposed/infected frogs sampled at various times post-exposure were designated 
Groups 1, 2, 3 and 4, corresponding to being sampled at 4, 8, 14 and 28–30 days post exposure, respectively. 
Box hinges represent first and third quartiles, and middle represents the median. Whiskers extend 1.5 times the 
inter-quartile range of the hinge. Boxes are ordered by relative metabolite importance.
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associated with the tricarboxylic acid (TCA, Krebs or citric acid) cycle that were depleted in tissues of moribund 
frogs included α-ketoglutaric, glutamic, aspartic, citric and fumaric acids (Figs 3 and 4). Low concentrations of 
citric, fumaric, α-ketoglutaric, and glutamic acids, as well as fructose-6-phosphate, beta-alanine, glycine, hypox-
anthine and guanine suggested reduction in the function of energy generating fermentation pathways including 
degradation of purine nucleobases and fermentation of pyruvate. These results are consistent with the traditional 
statistical analyses, but build a more comprehensive picture of the effect of chytridiomycosis on respective systems 
and subsystems.
Population comparisons. Univariate analyses. One-way ANOVA of skin samples grouped according to 
population revealed 11 metabolites differing significantly in relative concentration between populations based 
on Tukey’s HSD post-hoc tests, 6 of which were unable to be matched to our libraries (populations Eucumbene, 
Grey Mare and Kiandra contained 19, 17 and 15 samples respectively). Those metabolites identified included pan-
tothenic acid, myo-inositol, leucine, isoleucine and creatine (Fig. 5; Supplementary Table S9). The t-test template 
matching approach with the pattern Eucumbene-Grey Mare-Kiandra (described below) yielded the following sig-
nificant metabolites: pantothenic acid, isoleucine, leucine, creatine and ribose (Supplementary Table S10). SAM 
results identified pantothenic acid, myo-inositol, creatine and leucine as significantly different between popula-
tions (Supplementary Table S11). There were no metabolites from liver samples identified with any significantly 
differing relative concentrations between populations with FDR < 0.05 (sample sizes for these analyses included 
Eucumbene, Grey Mare and Kiandra containing 20, 18 and 20 samples respectively).
Multivariate analyses. Minimal separation of population clusters was apparent with supervised PLS-DA for 
both skin and liver tissue samples. Clustering was more pronounced with the skin samples, where samples from 
Grey Mare (Bd-naïve population) projected between clusters of samples from the two long Bd-exposed pop-
ulations (Kiandra and Eucumbene) (Fig. 6). Top ranked identified metabolites contributing to this mild effect 
for skin samples grouped by population using VIP scores included pantothenic acid, aspartic acid, threonine, 
creatine, guanine, serotonin, methionine, and leucine (when ranked on component 1; Supplementary Table S12). 
Correspondingly for liver samples, the most important metabolites included turanose, urea, thymine, lysine, 
myo-inositol, fructose-6-phosphate, sucrose, α-ketoglutaric acid, β-alanine, and cellobiose (Supplementary 
Table S13).
Discussion
In this study we analysed the metabolic response of an amphibian host to chytridiomycosis with a focus on the 
small, polar metabolites amenable to analysis by gas chromatography. Our results clearly demonstrate marked 
effects of clinical chytridiomycosis on organism-wide metabolism, not limited to either the site of infection (skin) 
or effects on plasma electrolyte balance that had previously been described10. Clinical chytridiomycosis dramat-
ically interrupted tissue homeostasis; affecting numerous biosynthetic and degradation pathways, and causing 
pronounced dysregulation of cellular energy metabolism in both the skin and liver tissues. We identified several 
key metabolites that may provide targets for research and intervention, and may help explain differences in sus-
ceptibility. The 20 key differentially abundant metabolites identified included α-ketoglutarate (2-oxoglutarate), 
isoleucine, pantothenate, serotonin, glutamate, myo-inositol, putrescine, 5HIAA, adenine, galactose, leucine, 
pyroglutamate, creatine, threonine, citrate, aspartate, tartrate, ribose, guanine, and adenosine (see Table 3 for key 
metabolite details). To our knowledge this is the first non-targeted metabolomics study of amphibian host skin 
and liver tissue responses to chytridiomycosis.
Figure 2. Partial Least Squares discriminant analysis (PLS-DA) scores plots of components one and two, 
comparing skin samples (A) and liver samples (B) as they cluster by sampling group. Sham-exposed negative 
control group frogs were designated Group 0. Exposed/infected frogs sampled at various times post-exposure 
were designated Groups 1, 2, 3 and 4, corresponding to being sampled at 4, 8, 14 and 28–30 days post exposure, 
respectively.
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The L. v. alpina metabolome of clinically diseased frogs was distinctly divergent from both unexposed control 
and subclinically Bd-infected frog groups, likely associated with end-stage pathophysiological changes occurring 
in the tissues shortly prior to disease-induced mortality10. The most important effect was the organism-wide dis-
ruption of cellular energy pathways in moribund frogs, particularly the tricarboxylic acid (TCA, Krebs or citric 
acid) cycle, glycolysis, and anaerobic fermentation pathways (Figs 3 and 4)41. The TCA cycle is central to cellular 
energy metabolism and also plays a role in providing substrates for numerous biosynthetic pathways. The func-
tion of the TCA cycle is to produce energy in the form of adenosine triphosphate (ATP) from the oxidation of 
acetyl-CoA44 which is primarily derived from dietary sources (sugars, fats and proteins) in the healthy fed state. 
Here we found that several key intermediates of the TCA cycle and their anaplerotic precursors were significantly 
depleted in skin and liver tissues from frogs of all populations showing clinical signs of chytridiomycosis (sam-
pled at 28–30 days post-exposure), relative to negative control and subclinically infected frogs. These metabolites 
included α-ketoglutarate, glutamate, citrate, fumarate and aspartate (Fig. 1). In contrast, the remaining interme-
diates including pyruvate, acetyl CoA and succinyl CoA were not identified as significantly depleted and several 
of their anaplerotic precursors were found to be relatively elevated in both tissues (including isoleucine, leucine, 
glycine and lysine). Together, our findings suggest imbalance of TCA cataplerotic and anaplerotic processes, lead-
ing to disruption of energy production in the clinically diseased state44.
Within liver samples of clinically diseased frogs we also identified significant reduction in the relative concen-
tration of three glucose precursors (galactose, fructose-6-phosphate and glucose-6-phosphate)45 compared with 
negative controls and subclinically infected frogs (Fig. 1B). As the liver is the key site for gluconeogenesis and a 
critical organ for energy metabolism46, these findings are consistent with organism-wide energy dysregulation 
in clinical chytridiomycosis. Anorexia (lack of appetite) is one of the first clinical signs of chytridiomycosis47. 
Together with infection-associated energy losses48, anorexia could lead to energy dysregulation in diseased frogs, 
and may contribute to the observed lethargy of the moribund state.
The accumulation of essential branched-chain amino acids (BCAAs) such as isoleucine and leucine in the 
moribund state is likely a by-product of tissue protein breakdown49 for gluconeogenesis or through toxic effects. 
Figure 3. Relative accumulation levels of skin metabolites (from frogs grouped by sampling period) associated 
with key cellular systems (A) Biosynthesis, (B) Degradation, (C) Energy, and (D) relative accumulation 
data for tricarboxylic acid cycle subsystem intermediates. Large dots represent mean data values for relevant 
metabolites involved in various subsystems, and small dots represent individual metabolite values. Vertical axis 
represents normalized relative metabolite accumulation values. Solid colour bars provide the cumulative sum 
of data values for relevant metabolites, and are more pronounced where many metabolites make a consistent 
contribution to change within a subsystem.
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Isoleucine was the most significantly elevated metabolite in the liver samples of clinically diseased frogs, but it 
was also significantly elevated in skin samples. Leucine was significantly elevated in the liver of clinically diseased 
frogs (Fig. 1). Unlike other amino acids, leucine and isoleucine have limited gluconeogenic capacity (ability to be 
converted to glucose for energy), and they are also not subject to hepatic metabolism50 as the liver lacks substan-
tial branched chain amino-transferase enzyme for the conversion of BCAAs to branched chain α-ketoacids. For 
eventual elimination these BCAAs require terminal oxidation through the TCA cycle44, however, in dysregulated 
energy states as described above, this might be expected to lead to the resultant accumulation as determined here. 
Elevated BCAAs and the accumulation of their toxic intermediates is characteristic of organic acidurias (such as 
maple syrup urine disease), and these metabolic disorders have been linked with neurotoxicity and ketoacidosis 
among other signs51.
In contrast to elevated BCAAs, pathway analysis41 indicated that other amino acids were predominantly depleted 
in the moribund state and that their biosynthetic and degradation pathways were affected, particularly in skin tis-
sues. In most cases this was linked with the depletion of α-ketoglutarate and glutamate. Additionally, the function 
of numerous other biosynthetic and degradation pathways was found to be compromised in clinically diseased 
animals, suggesting generalized failure of cellular homeostatic mechanisms and secondary functions. The most 
significantly affected pathways included nucleotide, carbohydrate, secondary metabolism, cofactor, and hormone 
biosynthesis and degradation as well as metabolic regulatory pathways (Fig. 3). Metabolites associated with detox-
ification pathways were also substantially depleted in the skin of moribund frogs, particularly those related to the 
synthesis of defense compounds with antibiotic effects, but also those associated with reactive oxygen species, acid 
resistance, and biological toxins. These findings are consistent with the production of antimicrobial peptides as 
demonstrated by other studies12,52–54, and they are also consistent with the failure to detoxify harmful products 
from the processes of inflammation and the pathogen itself (for example, several recent studies have characterized 
Bd metabolites with the capacity to inhibit lymphocyte responses32,55,56). Although studies have not demonstrated 
effects of chytridiomycosis on blood acid-base balance57, the evidence for reduced function of acid resistance path-
ways may be due to over utilization of buffering mechanisms due to excess BCAAs. Our results may indicate that 
systemic metabolic disruption due to infection with Bd may contribute to disease signs.
As an example of toxin accumulation, putrescine was found to be significantly elevated in the skin and liver of 
clinically diseased frogs in comparison with control and subclinically infected frogs (Fig. 1). Putrescine is a pol-
yamine breakdown product of amino acids so named for its foul odour and association with decaying flesh58. As 
such, increased concentrations of putrescine may be an indicator of catabolism and were likely responsible for the 
putrid smell of infected individuals (as reported anecdotally by colleagues). Although putrescine could be asso-
ciated with post-mortem autolysis during tissue collection, this cause is unlikely as putrescine was significantly 
Figure 4. Schematic representation of key intermediates and enzymes involved in the tricarboxylic acid 
(TCA) cycle. The relative concentration of three key metabolites (citrate, α-ketoglutarate [2-oxoglutarate] and 
fumarate) is illustrated with the coloured boxes, representing the respective frog sample groups from left to 
right: (i) negative controls, (ii) 4 days post exposure (DPE), (iii) 8 DPE, (iv) 14 DPE, and (v) moribund.
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positively correlated with sampling group (with controls from Group 0 exhibiting the lowest concentrations, 
regardless of actual sampling date). Putrescine is also active in immune processes and basic homeostatic mecha-
nisms59,60. Interestingly, ornithine, and the polyamines putrescine and agmatine, are potent inducers of a trichoth-
ecine mycotoxin of Fusarium graminearum, whereby mycotoxin production is linked to the natural accumulation 
of these metabolites within the host61. These metabolites may thus also be tightly coupled to clinical signs of 
disease in moribund animals.
Common to several of the pathway disruptions we have discussed thus far is the severe depletion of both 
α-ketoglutarate and the amino acid glutamate. These metabolites were significantly depleted in both skin and 
liver tissues of clinically diseased frogs, with α-ketoglutarate identified as the metabolite with the most signifi-
cantly decreased concentration in the skin samples, and glutamate the second most significantly reduced in the 
liver samples. Enzymatically linked pyroglutamate was also significantly depleted in both skin and liver tissues 
(Fig. 1). Alpha-ketoglutarate and glutamate are closely metabolically linked (bidirectional reaction catalyzed by 
glutamate dehydrogenase or transaminases), typically ubiquitous among tissues, and recent studies have con-
firmed α-ketoglutarate as a master regulatory metabolite62–66. Depletion of these metabolites may be both causal 
and a consequence of multiple pathophysiological features of clinical chytridiomycosis in the amphibian host, 
although it is as yet unknown whether depletion due to utilization by Bd may also be involved.
Glutamate itself functions as the most abundant excitatory neurotransmitter in the vertebrate nervous sys-
tem67. Although we did not examine brain tissues, if glutamate depletion is systemic this could contribute to the 
loss of alertness and righting reflex observed in clinically diseased animals68. Alpha-ketoglutarate and glutamate 
are also precursors for GABA which was similarly found depleted in both skin and liver tissues (Fig. 1). GABA is 
an inhibitory neurotransmitter at neuronal synapses, and it can also be found in peripheral tissues unrelated to 
Figure 5. Box and whisker plots (with data points overlaid) of the relative concentration of identified 
metabolites of interest from skin samples according to their population of origin (using geom_boxplot from 
ggplot2 R package). Box hinges represent first and third quartiles, and middle represents the median. Whiskers 
extend 1.5 times the inter-quartile range of the hinge. Boxes are ordered by relative metabolite importance.
Figure 6. Partial Least Squares discriminant analysis (PLS-DA) scores plots of components one and two, 
comparing skin samples (A) and liver samples (B) as they cluster by source population.
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Group Tissue
Metabolite identification
(TMS groups, RT, RI) ANOVA FDR Tukey’s HSD
Pattern 
matching
FDR Correlation SAM FDR
PLS-DA 
VIP
comp. 1
Time-series
Skin
a-Ketoglutaric acid, x TMS, 23.95, 1578 1.05E-05 4-0; 4-1; 4-2; 4-3 0.005854 −0.50794 0 2.2876
Serotonin, x TMS, 39.11, 2470 0.002533 4-0; 4-1; 4-2; 4-3 0 1.6147
Putrescine, x TMS, 22.45, 1506_putative 0.036876 3-0; 4-0 0.005854 0.50557 0.00909 2.0726
Adenine, 2 TMS, 29.74, 1869 0.036337 3-0; 4-0 0.005854 0.50493 0.00909 2.0262
5-Hydroxyindole-3-acetic acid, 3 TMS, 35.49, 2212 0.002533 4-0; 4-1; 4-2; 4-3 0.000346
L-Threonine, 3 TMS, 19.59, 1387 0.02635 3-0; 4-0 0.012166 −0.472 0.003239 1.99
L-Isoleucine, 2 TMS, 17.32, 1295 0.004158 4-0; 4-1; 4-2; 4-3 0.004607
DL-Tartaric acid 4TMS-like 0.021251 4-0; 4-1; 4-2 0.039136 −0.41978 0.00909
Glutamic acid, 3 TMS, 24.79, 1623 0.004834 4-0; 4-1; 4-2; 4-3 0.039136 −0.40884 0.003179
Adenosine, 4 TMS, 41.49, 2642 0.039136 0.41253 0.042185
Urea, 2 TMS, 16.14, 1249 0.02635 1-0; 3-1 0.000829
Serine, 2 TMS, 16.43, 1260 0.029108 3-0; 3-2 0.003179 1.719
DL-Ornithine, 3 TMS, 24.71, 1623 0.012299 2-1; 3-2; 4-2 0.003293
L-Pyroglutamic acid, 2 TMS, 22.76, 1520_saturated 0.032369 4-0; 4-2 0.039136 −0.39293 0.019789
L-Lysine, 4 TMS, 30.54, 1915 0.036876 2-1; 3-1; 4-1 0.006945 1.7061
Fumaric acid, 2 TMS, 18.29, 1357 0.02968 4-0; 4-3 0.027929
Aspartic acid, 2 TMS, 20.54, 1428 0.018362 1.651
Cellobiose, x TMS, 42.19, 2962 0.040882 0.38103 0.039192 1.496
g-Aminobutyric acid, 3 TMS, 22.9, 1526 0.0409 4-0; 4-1; 4-3 0.00909
Myo-Inositol, 6 TMS, 33.38, 2081 0.042804 −0.37252 0.032292
Liver
L-Isoleucine, 2 TMS, 17.32, 1295 3.51E-11 4-0; 2-1; 4-1; 3-2; 4-2; 4-3 4.15E-05 0.57373 0.003774 1.5512
L-Glutamic acid, 2 TMS, 22.7, 1519* 2.86E-10 4-0; 4-1; 4-2; 4-3 2.50E-06 −0.6347 0.011043 1.5014
5-Hydroxyindole-3-acetic acid, 3 TMS, 35.49, 2212 0.000582 4-0; 4-1; 4-2; 4-3 0.001556 0.45911 0.003029 2.5384
D–Galactose, 5 TMS, MEOX, 29.94, 1880 0.025509 4-0; 4-1 0.011265 −0.38718 0.003029 2.6805
L-Pyroglutamic acid, 2 TMS, 22.76, 1520_saturated 2.86E-10 4-0; 4-1; 4-2; 4-3 2.50E-06 −0.63459 0.011043 1.501
Citric acid, 4 TMS, 28.69, 1817 9.67E-07 4-0; 4-1; 4-2; 4-3 0.000752 −0.4873 0.003029 1.966
Putrescine, x TMS, 22.45, 1506_putative 5.64E-07 4-0; 4-1; 4-2; 4-3 6.71E-06 0.61232 0.003029 2.5008
a-Ketoglutaric acid, x TMS, 23.95, 1578 8.29E-05 4-0; 4-1; 4-2; 4-3 0.002517 −0.44337 0.003029 1.9493
L-Leucine, 2 TMS, 16.74, 1274 1.85E-08 4-0; 4-1; 3-2; 4-2; 4-3 4.18E-05 0.57127 0.011264
Creatine. x TMS, 23.39, 1551 6.32E-05 4-0; 4-1; 4-2; 4-3 0.000752 0.48784 0.003029 1.9563
D-Fructose-6-phosphate 6TMS, MEOX, 36.72, 
2300-put 5.97E-07 4-0; 4-1; 4-2; 4-3 0.002165 −0.44874 0.003029 1.8381
g-Aminobutyric acid, 3 TMS, 22.9, 1526 4.26E-05 4-0; 4-1; 3-2; 4-2 0.000315 −0.51611 0.004805 1.7973
D-Glucose-6-phosphate, 6 TMS, MEOX, 37.23, 2332 3.10E-06 4-0; 4-1; 4-2; 4-3 0.006038 −0.41173 0.003029
Fumaric acid, 2 TMS, 18.29, 1357 1.42E-06 4-0; 4-1; 4-2; 4-3 0.000934 −0.47769 0.005732
Serine, 3 TMS, 18.98, 1363 0.003442 3-0; 4-0; 4-1; 4-2 0.000661 0.49314 0.038474
L-Lysine, x TMS, 29.32, 1852 6.32E-05 4-0; 4-1; 4-2; 4-3 0.003008 0.4358 0.00402 1.5988
Urea, 2 TMS, 16.14, 1249 0.011043 1.5188
Glycine, 3 TMS, 17.63, 1308 0.048096 4-0 0.003008 0.43531
Sucrose, 8 TMS, 41.32, 2630.1 0.005833 1-0; 2-0; 3-1; 3-2 0.008361
Adenine, 2 TMS, 29.74, 1869 0.016867 4-0; 4-1; 4-2; 4-3 0.011043
Site
Skin
Pantothenic acid, O,O,O-TMS-putative 0.012106 G-E; K-E 0.010965 −0.51381 0.002488 2.1179
Myo-Inositol, 6 TMS, 33.38, 2081 0.017097 K-E; K-G 0.0199
L-Isoleucine, 2 TMS, 17.32, 1295 0.026777 K-E 0.010965 0.49005
L-Leucine, 2 TMS, 16.74, 1274 0.026777 K-E; K-G 0.010965 0.48099 0.039608 1.5988
Creatine. x TMS, 23.39, 1551 0.046951 K-E; K-G 0.016922 0.45692 0.036566 1.8447
Aspartic acid, 2 TMS, 20.54, 1428 1.9701
L-Threonine, 2 TMS, 17.37, 1298 1.8778
D–Ribose, 4 TMS, MEOX, 25.89, 1678 0.033096 0.42058
saturated_Guanine manual 1.7444
Serotonin, x TMS, 39.11, 2470* 1.7352
Liver
D–Turanose, 7 TMS, 42.29, 2702 2.7638
Urea, 2 TMS, 16.14, 1249 2.507
Thymine, 2 TMS, 19.94, 1403 2.4842
L-Lysine, 3 TMS, 26.54, 1712 2.0644
Myo-Inositol, 6 TMS, 33.38, 2081.1 1.8873
D-Fructose-6-phosphate 6TMS, MEOX, 36.72, 
2300-putative 1.7514
Sucrose, 8 TMS, 41.32, 2630.1 1.734
a-Ketoglutaric acid, x TMS, 23.95, 1578 1.6361
beta-Alanine, 3TMS, 20.58, 1429 1.6332
Cellobiose, x TMS, 42.19, 2962 1.4796
Table 3. Key metabolites in both skin and liver tissues discriminating between experimental groups (including 
sampling periods post exposure and populations), demonstrating overlap in significant results between 
univariate (ANOVA, t-test pattern matching and SAM) and multivariate analyses (PLS-DA, top 30 VIP scores 
ranked on component 1). Comparisons found to be significant with post-hoc Tukey’s HSD tests are listed, as are 
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neurotransmission69. GABA has additionally been linked to pathogenicity and sporulation in some filamentous 
fungi70. In mammals, glutamate plays an important role in nitrogen elimination, acting as a substrate for the 
formation of urea via the urea cycle in the liver64. As a semi-aquatic amphibian, the alpine tree frog is likely to 
at least partly rely on direct ammonia excretion in place of urea formation for removing excess nitrogen, so the 
significance of interruption of the urea cycle here is unknown.
Glutamate is a precursor for nucleic acid and protein synthesis, including importantly collagen synthesis via 
the proline pathway71. Skin hypertrophy and hyperplasia has been an occasional histological finding in diseased 
frogs72,73, and utilization of glutamate for collagen synthesis in response to infection may be contributing to its 
depletion. Interestingly, although proline was one of our identified metabolites, we did not detect any signifi-
cant differences in its accumulation during infection. Furthermore, glutamate is utilized during the synthesis of 
inflammatory acute phase proteins, which have been shown to accompany clinical chytridiomycosis43. Glutamate 
and α-ketoglutarate are also important for immune system function. Alpha-ketoglutarate has been called the 
‘immune nutrient factor’ as it is a crucial energy precursor for rapidly dividing cells, particularly immune cells66. 
Glutamate has been demonstrated to promote phagocytosis, and both α-ketoglutarate and glutamate promote T 
helper 1 differentiation, favouring immune function via the production of interferon-γ, tumor-necrosis factor 
beta and interleukin-274. We speculate that the dysregulation of metabolic pathways described above involv-
ing depleted α-ketoglutarate and glutamate may be driven primarily by an overwhelming but non-protective 
immune response in the later terminal stages of infection43.
We found several other metabolites that differed significantly between sampling groups. Serotonin was sig-
nificantly reduced in the skin of clinically diseased frogs, while 5HIAA was elevated in both the skin and liver 
of diseased frogs (Fig. 1). Serotonin and 5HIAA are both intermediates of tryptophan metabolism and there is 
growing evidence that they play an important role in anti-fungal host defense mechanisms75–78. Serotonin occurs 
within the skin of many vertebrates, including frogs and fish79. In humans, serotonin is produced within cutane-
ous melanocytes, and through metabolic processes within the skin is acetylated and subsequently methylated to 
form N-acetylserotonin80 and melatonin, respectively. The significance of these findings concerning serotonin 
and 5HIAA is not yet clear but is currently the subject of further study.
Serine and threonine were both identified as reduced in the skin of clinically diseased frogs, while serine was 
elevated in the liver of clinically diseased frogs. Serine and threonine are small, closely related, polar, pH neutral, 
nucleophilic amino acids bearing a hydroxyl group. It is possible that part of the increase in these ubiquitous 
amino acids may have been associated with the fungal pathogen as serine proteases have been identified in Bd 
transcriptomics studies81,82.
We also compared metabolic responses between populations with differing long-term evolutionarily exposure 
histories and phenotypic susceptibility to chytridiomycosis. From the concurrent large survival experiment42, 
frogs from long-exposed population Kiandra were more resistant (survived significantly longer) when com-
pared with frogs from the other populations. In this study we found that pantothenate, myo-inositol, isoleu-
cine, leucine, and creatine demonstrated highly significantly different concentrations in skin samples between 
populations (Fig. 5). The pattern of strongest association identified (except for pantothenate and myo-inositol) 
was Eucumbene-Grey Mare-Kiandra, which unexpectedly suggests that the Bd-naive population Grey Mare lies 
between the other two in terms of metabolite accumulation, in contrast to the clinical survival results. Univariate 
analyses revealed no metabolites with significantly different concentrations between populations in the liver sam-
ples. This was likely due to the liver’s central role as an important homeostatic organ in all populations, and the 
skin being more susceptible to external evolutionary selection pressures than the other organs due to fungal 
penetration.
Pantothenate demonstrated the most significant difference (across all analyses) in relative concentration 
between source populations, with skin samples from Eucumbene frogs having higher concentrations than 
samples from both Grey Mare and Kiandra. Pantothenate (otherwise known as vitamin B5) is an essential 
water-soluble vitamin for the synthesis of coenzyme-A (CoA) which is principally involved in energy (tricarbo-
xylic acid cycle) and fatty acid metabolism. This metabolite is also essential for the growth of pathogenic organ-
isms, including fungi83, and has been previously measured in developing frogs84. Analogues of pantothenate have 
even shown antimicrobial capabilities, as they prevent the uptake of the naturally occurring endogenous and 
essential metabolites85,86. Whilst there is no determined time series association, different amounts within the skin 
among frog populations may imply a selective pressure towards this difference. It is unclear, however, how differ-
ences in pantothenic acid relate to the clinical evidence of survival between the populations, since in the clutches 
we compared, frogs from Eucumbene were more susceptible to infection than those from Kiandra.
Interestingly, the metabolite composition of the skin (site of Bd infection) and liver tissues differed substan-
tially, consistent with the underlying differential physiology and biochemistry of these tissues, regardless of health 
or disease status (Supplementary Fig. S1). The skin tissue uniquely contained guanine, while the liver tissue was 
considerably richer in sugars and sugar phosphate metabolites. Guanine was identified as elevated in skin sam-
ples from Eucumbene and decreased in samples from Kiandra. This metabolite has been long known for its role 
as a pigment in the skin of amphibians87,88 and more recently characterized for its light reflective properties in 
the respective correlations for the pattern matching approach. Sham-exposed negative control group frogs were 
designated Group 0. Exposed/infected frogs sampled at various times post-exposure were designated Groups 
1, 2, 3 and 4, corresponding to being sampled at 4, 8, 14 and 28–30 days post exposure, respectively. Source 
populations (sites) are as follows: Eucumbene, Grey Mare, Kiandra are represented by E, G and K respectively. 
Where metabolites were not found to be significantly different with a particular test, values have been omitted. 
*Quantitation re-calculated from a lesser abundant ion (or isotope) within mass spectrum for accurate 
measurement of metabolites nearing the upper dynamic concentration of the MS.
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the scales of fish89 and chameleons90. As a point of interest, the other primary amphibian iridophore pigments87 
(purines hypoxanthine and adenine) were also identified in the L. v. alpina skin.
Many metabolites are ubiquitous in life, particularly intermediates of primary metabolism. Whilst the presence 
or absence of specific metabolites can be inferred from biochemical pathways annotated from the genome, tran-
scriptome or proteome, the metabolome is tightly coupled to the environment and resulting phenotype. Metabolites 
observed within diseased tissues may originate from the host or pathogen, as well as commensal organisms in super-
ficial (mucosae or epidermis) or gastrointestinal tissues. Metabolites of non-host origin could not all be unambig-
uously distinguished from the endogenous host metabolites with the methods utilized here yet this distinction in 
future pathogenesis studies may be worthwhile (for example, to evaluate the release of toxic fungal or bacterial 
metabolites). Here, we sought to clarify the origin by comparing the metabolite profiles of the host to that of Bd 
in culture (data not shown) for an exclusionary approach to dissecting the origin of metabolites as frog or fun-
gal, although the expression of the fungal metabolome will likely differ between an in vitro and parasitic life cycle. 
Unsurprisingly a select few metabolites were specific to only one or other of the frog tissues, including the measured 
sugar phosphates, which were associated with liver tissues, and other metabolites with roles outside of primary 
metabolism. Although, the influence of fungal metabolites within the measurements was likely negligible compared 
to that of the frog tissues, these measurements are nonetheless important for dissecting this pathosystem.
Depending on the regulatory mechanisms, and proximate metabolite source or relationship to gene and pro-
tein expression, a systems biology approach may greatly assist in understanding these complex host-pathogen 
relationships. Future approaches could include (1) comparing the metabolomes of infected frogs, with those 
that have been treated with an antibiotic to reduce or eliminate bacterial load, (2) biolabeling (for example, using 
visual or otherwise detectable tags, such as green fluorescent protein or stable isotopic labelling), or alternatively 
(3) mass spectrometry imaging to examine the source of metabolites. The concentration of metabolites in tissues 
is also reliant on their flux; the rate of production (upstream processes), but also their rate of modification, anabo-
lism or catabolism to other metabolites, or removal from the system91. The inclusion of fluxomics data would also 
likely provide further detail of metabolite origin. Further work on assessing the importance of the specific metab-
olites (particularly α-ketoglutarate, glutamate, serotonin, putrescine, pantothenate, serine and threonine) could 
include examination of the tissue metabolome of other amphibian species. Further studies could also include 
targeted functional validation studies to characterize metabolite role by blocking production within the host, 
inhibiting activity within skin explants ex vivo, or testing the effect on Bd growth in vitro92.
To our knowledge, this study was the first to apply a non-targeted metabolomics approach to a fungal wildlife 
disease and specifically to dissect the host-pathogen interface through analysis of host tissues. We demonstrated 
that the metabolome of clinically diseased frogs diverged distinctly from that of subclinically Bd-infected frogs 
and unexposed control groups. We found that chytridiomycosis dramatically affected organism-wide homeostatic 
mechanisms, including interruption of biosynthetic and degradation pathways as well as causing dysregulation 
of cellular energy metabolism. Depletion of α-ketoglutarate and glutamate appeared central to these changes. 
This was also uniquely the first metabolomics investigation of the alpine tree frog, and as such we have revealed 
numerous interesting observations on the composition of the L. v. alpina skin and liver tissues. Metabolites relat-
ing to differences in the population of origin, which may be associated with variation in phenotypic resistance or 
tolerance between populations were also uncovered. Most notably, the differences in metabolite expression that 
we have identified may be characteristic of processes involved in chytridiomycosis across host species, and may 
have broad relevance to understanding the pathogenesis of fungal skin diseases and future control of devastating 
fungal pathogens such as Bd.
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